Estimation of Health-State Utility Values and Factors Driving Health-Related Quality of Life in People Living with HIV and AIDS and Receiving cART in Germany: Baseline Analysis of a Cohort Study
-
Published:2021-03-30
Issue:
Volume:
Page:
-
ISSN:1871-2584
-
Container-title:Applied Research in Quality of Life
-
language:en
-
Short-container-title:Applied Research Quality Life
Author:
Treskova MartinaORCID, Scholz Stefan, Kuhlmann Alexander, Mahlich Jörg, Stoll Matthias
Abstract
AbstractHIV has become a chronic disease since widespread of combined antiretroviral therapy (cART). Understanding the influence of therapeutic and preventive interventions on health-related quality of life (HRQoL) of people living with HIV and AIDS (PLWHA) is important. Information about health state utilities and HRQoL in PLWHA after the introduction of cART is limited, especially in Germany. The study aims to estimate and describe health state utilities and HRQoL in PLWHA in Germany and explore the effects of patient characteristics, clinical and treatment factors. Utilities and HRQoL in PLWHA in Germany were measured with the generic EQ-5D-3L questionnaire. Health state utilities were calculated based on the EQ-5D descriptive system using the German EQ-5D-3L time trade-off (TTO) value set. HRQoL was calculated based on the EQ visual analogue scale (EQ-VAS). Extensive descriptive analyses were performed to represent utility values for different groups of the patients. Generalized linear models (GLMs) with beta-inflated distributions were used to determine patient characteristics and clinical factors that influence TTO utilities and VAS scores. 1056 PLWHA completed the EQ-5D-3L questionnaires at the beginning of the study. The mean TTO utility value is 0.912 (SD ± 0.154), and the mean VAS HRQoL is 84.32 (SD ± 18.55). “Anxiety/depression” and “pain/physical discomfort” are the most affected dimensions. A longer period of living with HIV, a lower CD4-cell count, having symptomatic HIV or AIDS and an increased number of changes in therapy are associated with decreased utilities and a lower probability of having HRQoL of perfect health. No significant effect of duration of regimen was found. Depression significantly decreases TTO utility values. Higher education, full-time employment and female gender are associated with higher utilities. The resulted EQ-VAS values for PLWHA in Germany are comparable with EQ-VAS estimates for the general population. The obtained estimates can be used as inputs for health economic evaluations of HIV-interventions. Addressing anxiety and depression may reduce the quality of life impairment in PLWHA. Impact of comorbidities needs further investigation.
Funder
Janssen-Cilag grant
Publisher
Springer Science and Business Media LLC
Subject
Life-span and Life-course Studies
Reference53 articles.
1. Airoldi, M., Zaccarelli, M., Bisi, L., Bini, T., Antinori, A., Mussini, C., et al. (2010). One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects. In Patient preference and adherence, 4, 115–125. 2. Bing, E. G., Hays, R. D., Jacobson, L. P., Chen, B., Gange, S. J., Kass, N. E., Chmiel, J. S., & Zucconi, S. L. (2000). Health-related quality of life among people with HIV disease: Results from the multicenter AIDS cohort study. In Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 9(1), 55–63. 3. Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292. 4. Briggs, A, H., Claxton, K., Sculpher, M, J. (2011): Decision modelling for health economic evaluation. Oxford: Oxford University Press (Handbooks in health economic evaluation series). Available online at http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1689059. 5. Briongos Figuero, L. S., Bachiller Luque, P., Palacios Martín, T., González Sagrado, M., & Eiros Bouza, J. M. (2011). Assessment of factors influencing health-related quality of life in HIV-infected patients. HIV Medicine, 12(1), 22–30. https://doi.org/10.1111/j.1468-1293.2010.00844.x.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|